Search

everythinglearnresearchcommunity

for

Search:↓

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Diphencyprone treatment for alopecia areata can cause vitiligo in some patients.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

TNF-a may not be as involved in certain types of hair loss as previously thought.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Diffuse hair loss in women is often linked to thyroid problems.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Steroids may not work well for alopecia areata because of high unoccupied receptors and low thioredoxin levels.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.